16714-248-01 |
16714-248 |
HUMAN PRESCRIPTION DRUG |
Fosaprepitant |
Fosaprepitant dimeglumine |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20230128 |
N/A |
ANDA |
ANDA214616 |
NorthStar RxLLC |
FOSAPREPITANT DIMEGLUMINE |
150 mg/5mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (16714-248-01) / 5 mL in 1 VIAL, SINGLE-DOSE |
31722-165-31 |
31722-165 |
HUMAN PRESCRIPTION DRUG |
Fosaprepitant |
Fosaprepitant dimeglumine |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20210729 |
N/A |
ANDA |
ANDA214616 |
Camber Pharmaceuticals, Inc. |
FOSAPREPITANT DIMEGLUMINE |
150 mg/5mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (31722-165-31) / 5 mL in 1 VIAL, SINGLE-DOSE |
68001-523-36 |
68001-523 |
HUMAN PRESCRIPTION DRUG |
Fosaprepitant |
Fosaprepitant dimeglumine |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20220202 |
N/A |
ANDA |
ANDA214616 |
BluePoint Laboratories |
FOSAPREPITANT DIMEGLUMINE |
150 mg/5mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (68001-523-36) / 5 mL in 1 VIAL, SINGLE-DOSE |